DSpace Collection: La divulgación en Dadun puede ser tenida en cuenta y afectar negativamente a la patentabilidad futura de resultados incluidos en la presentación. Si el investigador o su grupo prevén que los resultados expuestos en la presentación, o parte de ellos, pueden ser o serán objeto de una solicitud de patente posterior no deberán incorporar dicha presentación en Dadun. En tal caso se le recomienda consultar con el ICT la manera más adecuada de procederLa divulgación en Dadun puede ser tenida en cuenta y afectar negativamente a la patentabilidad futura de resultados incluidos en la presentación. Si el investigador o su grupo prevén que los resultados expuestos en la presentación, o parte de ellos, pueden ser o serán objeto de una solicitud de patente posterior no deberán incorporar dicha presentación en Dadun. En tal caso se le recomienda consultar con el ICT la manera más adecuada de procederhttps://hdl.handle.net/10171/197622024-03-29T11:40:26Z2024-03-29T11:40:26ZTrastornos neuropsiquiátricos en la enfermedad de Parkinsonhttps://hdl.handle.net/10171/227672020-03-03T23:14:02Z2001-01-01T00:00:00ZTitle: Trastornos neuropsiquiátricos en la enfermedad de Parkinson
Abstract: This paper reviews the main neuropsychiatric disorders associated with Parkinson’s disease (PD) and
describes the neuropathological hypothesis proposed to explain these symptoms. Development. This disease is usually associated
with neuropsychiatric complications such as depression, anxiety and apathy. Besides, psychiatric symptoms are one of the
most common side effects of antiparkinsonian drug-therapy. Conclusions. Depression is the most frequent emotional disorder
reported in patients with PD. Up to 20% of parkinsonian patients meet DSM-IV criteria for major depressive episode and another
20% for dysthymia, while the prevalence of depression in normal aged population is about 2-8%. The relationship between PD
and depression has not been fully established. Some investigators have suggested that depressive symptoms in PD are causally
related to the underlying neuropathological process, affecting predominantly serotoninergic and dopaminergic pathways.
Alternatively, depression in PD may represent a normal reaction to the progressive physical impairment induced by the disease.
Otherwise, up to 20% of parkinsonian patients present levodopa-induced psychiatric complications. Visual hallucinations are
the commonest, but delusions, confusional states, sexual disorders and sleep disorders have also been described. Serotonine and
dopamine have been implicated in the neuropathological basis of these disorders.2001-01-01T00:00:00ZLa visión parkinsoniana de la figura compleja de Rey-Osterriethhttps://hdl.handle.net/10171/227602020-03-03T21:07:01Z1999-01-01T00:00:00ZTitle: La visión parkinsoniana de la figura compleja de Rey-Osterrieth
Abstract: Visuospatial impairment has been frequently reported in Parkinson’s disease (PD). We present the progressive
distorsioned performance of the Rey-Osterrieth complex figure in parkinsonian patients at different stages of the disease (PD
de novo, PD on long-term treatment, PD with phychosis and PD with dementia)1999-01-01T00:00:00ZAspectos clínicos y factores pronósticos en la hemorragia intracerebralhttps://hdl.handle.net/10171/227582020-03-03T11:10:01Z2000-01-01T00:00:00ZTitle: Aspectos clínicos y factores pronósticos en la hemorragia intracerebral
Abstract: Intracerebral hemorrhage represents approximately 20% of all
strokes. In spontaneous intracerebral hemorrhage the essential etiological factor
is arterial hypertension, and the most frequent site the putamen and lobes of the
cerebrum (lobar hematoma). The mortality is higher than in cerebral infarct,
although the long-term prognosis is similar. DEVELOPMENT: We review the most
relevant forms of presentation and clinical findings of intracerebral hemorrhage
in adults, which show a combination of symptoms common to all types of hematoma
and those symptoms which depend on their site. We also analyse the factors and
studies which have sought to recognize variables predicting morbimortality.2000-01-01T00:00:00Z